Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

38.56 USD -0.68 (-1.74%)
Streaming Delayed Price Updated: 1:31 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
As COVID-19 cases hit 25 million, Dr. Fauci says it’s ‘conceivable’ we’ll know if there’s a safe vaccine by November
The infectious-disease expert said, ‘I would say a safe bet is at least knowing that you have a safe and effective vaccine by November, December.’ 
Tags PFE MRNA SAN
From MarketWatch
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barringupdates on coronavirus ... 
Tags AFIB CSTL Benzinga
From Benzinga
Friday Market Review - Friday, August 28
In July, the PMI was barely positive at 50.9, and the forecast was a mere 51.9 for this month. Unsurprisingly, input cost inflation was also at its high since January of 2019. The rise in input costs... 
Tags Gold/Precious Metals Energy Technology
From Blogs - TalkMarkets
Veeva Systems Earnings Beat Views; Firm Raises Fiscal Year Outlook
Late Thursday, life sciences software maker Veeva Systems reported earnings and sales that beat Wall Street expectations and hiked its outlook for the year; VEEV stock rose after hours. 
From Investor's Business Daily
3 Stocks to Buy Ahead of the Next Market Crash
These companies are all trading at cheap multiples relative to their earnings. 
Tags SNY VZ KO
From Motley Fool
U.K. abandoned herd immunity, while Sweden embraced it — how possible is it to achieve herd immunity without a vaccine?
In the absence of therapeutic treatments or a vaccine for the novel coronavirus, herd immunity suggests that there’s safety in numbers. But how realistic is that goal? 
Tags PFE MRNA SAN
From MarketWatch
Got $1,000? These Dirt-Cheap Stocks Are Practically Free
These rough and tumble coronavirus stocks could help fund your retirement. 
Tags SNY PFE BNTX
From Motley Fool
AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FT
COVID-19 vaccine makers are lobbying the European Union for protection against lawsuits, should problems arise with new therapies, the ... 
Tags AZN Market News Covid/19
From Benzinga
My husband wants 50% of my mother’s inheritance because he earns more than me. I said no. Am I being unreasonable?
I said I was willing to get a money manager and set up a retirement account in both of our names. I’ve always worked, even while raising our daughter. 
Tags AZN DJIA BNTX
From MarketWatch
My sister-in-law moved in with her mother, changed her will, set up a new trust and inherited everything. Is it too late to claim what rightfully belongs to us?
‘She is a compulsive liar and has not been honest about anything concerning the trust. There is talk about elder abuse.’ 
Tags ID:MERK SAN GSK
From MarketWatch
A common medication for older adults improves COVID-19 survival rates, researchers say
The meta-analysis led by a team from the University of East Anglia in the U.K. involved more than 28,000 patients. 
Tags Personal Finance COMP SPX
From MarketWatch
How The Parts Add Up: PPH Headed For $75
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Why one fund manager says today’s stock prices are unsustainable
In a week in which the S&P 500 set a record in the midst of a pandemic, it’s fair to at least consider the bottom 495 or so components. 
Tags ES00 NQ00 YM00
From MarketWatch
In a Native American community in Michigan’s Upper Peninsula, COVID-19 has been felt in unexpected ways
Temporary tents will be put up in the parking lot of Keweenaw Bay Ojibwa Community College to accommodate some classes, until cold weather sets in. 
Tags JNJ Health/Care General
From MarketWatch
Why Is Everyone Talking About Pfizer?
Its coronavirus vaccine effort is grabbing headlines, but this company isn't a one-trick pony. 
Tags Market News GSK MYL
From Motley Fool
My husband and I are worth $3.7 million, but I’m afraid I’ll spend my way into the poor house if he dies before me. When I was single, I bounced checks. What can I do?
‘He earns all the money and handles all our finances. I love to spend money and have a head-in-the-sand approach to money problems.’ 
Tags Entertainment and Leisure MRNA SAN
From MarketWatch
Market Mania
Swiss Roche with Regeneron REGN will make 3.5 mn doses of a future virus jab. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Is It Too Late to Buy VBI Vaccines Shares?
If you're hoping this biotech will win big with its coronavirus vaccine candidate, you may be looking in the wrong place. 
Tags Market News GSK MRNA
From Motley Fool
Johns Hopkins scientists examining weird side effects of COVID-19 say this could be how virus ‘gains a foothold in the body’
These findings could offer one reason why COVID-19 is so infectious and potentially offer clues to more effective treatments, researchers say. 
Tags JNJ Health/Care General
From MarketWatch
2 Ultra-Risky Biotech Stocks That Could Make You Filthy Rich
Consider the risks before taking any chances with these clinical-stage drugmakers. 
Tags GSK Market News CVAC
From Motley Fool
Another warning from 1918 Spanish flu for COVID-19: ‘Survival does not mean that individuals fully recovered’
‘We may never know the true mortality consequences of 1918 because of incomplete or inaccurate record keeping, issues that also undermine our ability to quantify the impact of COVID-19.’ 
Tags SAN ID:MERK GSK
From MarketWatch
My coworkers cough and sneeze, don’t wear masks, and talk about their parties. I’m worried about coronavirus. What do I do?
‘There have been several COVID-19 cases at my company. People have been out for at least two weeks because they were either sick or thought they had coronavirus.’ 
Tags SPX COMP Travel
From MarketWatch
Sanofi To Purchase Immune System-Focused Drugmaker Principia Biopharma For $3.7B
Sanofi SA will acquire Principia Biopharma Inc for $3.68 billion in cash, the two companies announced Monday. 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
Sanofi To Acquire Partner Principia Biopharma, Expand MS Treatment Efforts
Sanofi is expanding efforts to combat MS and other autoimmune diseases by announcing a $3.68 billion acquisition of partner Principia Biopharma. 
From Investor's Business Daily
My roommate tested positive for COVID-19. The nursing home where I work told me to come in. If I don’t work, they’ll fire me. What do I do?
More than 3,400 nursing homes in the U.S. have been cited for noncompliance with infection-control requirements and/or failure to report COVID-19 data. 
Tags Personal Finance COMP SPX
From MarketWatch
Sanofi To Purchase Immune System-Focused Drugmaker Principia Biopharma For $3.7B
Sanofi SA (NASDAQ: SNY) will acquire Principia Biopharma Inc (NASDAQ: PRNB) for $3.68 billion in cash, the two companies announced ... 
Tags Market News M&A Benzinga
From Benzinga
My friends’ wedding reception was canceled. They’re having a small ceremony next month. I’m invited to a party next year. Do I send a gift?
‘The wedding itself was put off because of the coronavirus pandemic.’ 
Tags Financial Services AZN SAN
From MarketWatch
When will I get my extra $300 a week in unemployment benefits? Why isn’t everyone out of work eligible under Trump’s proposal?
Trump signed an executive order calling for an extra $300 a week in unemployment benefits — but it’s best to read the small print. 
Tags AZN Food and Beverage Services/Consulting
From MarketWatch
Dr. Fauci outlines 3 ways America can beat coronavirus
The infectious-disease expert said, ‘Unless we do this together, we’re not going to get this under control.’ 
Tags BNTX DJIA AZN
From MarketWatch
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?
AstraZenca, GlaxoSmithKline, Novartis and Eli Lilly are using artificial intelligence systems to help in drug development, decision-making, and more. 
Tags GSK LLY Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.